✦ LIBER ✦

N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: A pilot study with dextromethorphan

✍ Scribed by J. L. Montastruc; N. Fabre; O. Rascol; J. M. Senard; O. Blin

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 165 KB
Volume: 9
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870090226

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential interaction of competitive

Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease

✍ Peter-Andreas Löschmann; Ullrich Wüllner; Michael T. Heneka; Jörg B. Schulz; Mar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 3 views

1-aminomethyl-5,6-dihydroxy-3-phenylisochroman; NMDA antagonist; CPP; 3-((6)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid

ChemInform Abstract: EMD 95885, a New El

ChemInform Abstract: EMD 95885, a New Eliprodil Analogue with Higher Affinity for the N- Methyl-D-aspartate (NMDA) Receptor.

✍ J. LEIBROCK; H. PRUECHER; W. RAUTENBERG 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB

Synthesis and N-Methyl-D-aspartate (NMDA

Synthesis and N-Methyl-D-aspartate (NMDA) Antagonist Properties of the Enantiomers of α-Amino-5-(phosphonomethyl)[1,1′-biphenyl]-3-propanoic Acid. Use of a New Chiral Glycine Derivative

✍ Werner Müller; David A. Lowe; Hans Neijt; Stephan Urwyler; Paul L. Herrling; Den 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 German ⚖ 694 KB

Open-label flexible-dose pilot study to

Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease

✍ Joseph H. Friedman; Robert M. Berman; Christopher G. Goetz; Stewart A. Factor; W 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

## Abstract Psychosis affects at least 5% to 8% of medication‐treated patients with idiopathic Parkinson's disease (PD). Treatment options include reducing medications used for the treatment of PD‐related motor symptoms or introducing an atypical antipsychotic drug. Only clozapine has been demonstr

Intravenous boluses and continuous infus

Intravenous boluses and continuous infusions of L-DOPA methyl ester in fluctuating patients with Parkinson's disease

✍ Dr. F. Stocchi; S. Ruggieri; A. Carta; J. Ryatt; N. Quinn; P. Jenner; C. D. Mars 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

## Abstract In six patients with Parkinson's disease exhibiting severe “on‐off” phenomena, a 200‐mg intravenous bolus of either L‐DOPA or of its methyl ester were equally effective in reversing motor deficits, although the duration of action of the methyl ester was shorter. There were no marked dif